figshare
Browse
data.zip (1.63 MB)

Efficacy and safety of PD-1/L1 as first-line treatment for advanced or metastatic urothelial carcinoma ineligible for platinum-based chemotherapy

Download (1.63 MB)
journal contribution
posted on 2024-03-12, 14:33 authored by ZHILONG HUANGZHILONG HUANG

To evaluate the efficacy and safety of PD-1/L1 inhibitors as first-line therapy in advanced or metastatic urothelial carcinoma ineligible for platinum-based chemotherapy.


History

Usage metrics

    Categories

    Keywords

    PD-1/PD-L1 inhibitorprogrammed cell death protein 1 inhibitorurothelial carcinomaineligible for platinum-based chemotherapy

    Licence

    CC BY 4.0

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC